Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Refractory to Taxane Regimens

NCT00073151 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00073151
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00073151 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of ABT-751 in Patients With Non-Small Cell Lung Cancer Refractory to Taxane Regimens
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2003
Completion date
January 31, 2006
Enrollment
30 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer